Exchange: NASDAQ·Updated 07:54 PM EST

OPK News

News
all
press releases
BDX Stock Down in Pre-Market Despite Q4 Earnings & Revenue Beat
BD stock lost 6.4% in pre-market trading despite Q4 earnings and revenue beat, as its subdued fiscal 2027 revenue growth outlook raises investor concerns.
Zacks
BDX Stock Down in Pre-Market Despite Q4 Earnings & Revenue Beat
BD stock lost 6.4% in pre-market trading despite Q4 earnings and revenue beat, as its subdued fiscal 2027 revenue growth outlook raises investor concerns.
Zacks
More News
Here's Why You Should Hold Solventum Stock in Your Portfolio for Now
SOLV's strong Q2 performance, growth investments and cost-saving program support its outlook, though higher raw material costs remain a concern.
Zacks
OPKO Health (OPK) Reports Q3 Loss, Misses Revenue Estimates
OPKO Health (OPK) delivered earnings and revenue surprises of +28.57% and -51.97%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Cencora Q4 Earnings & Revenues Beat on Specialty Growth, Margins Expand
COR's Q4 earnings and revenues beat estimates as specialty drug demand fuels growth and margins expand. The company raises its fiscal 2027 outlook.
Zacks
Reasons to Retain TransMedics Stock in Your Portfolio for Now
TMDX's OCS technology, robust pipeline and global expansion support growth prospects, but margin pressures and rising investments remain key concerns.
Zacks
Waters Q3 Earnings & Revenues Beat Estimates, 2026 Guidance Raised
WAT beats Q3 2026 earnings and revenue estimates, fueled by acquisitions and strong organic growth and raises its full-year revenue and earnings outlook.
Zacks
RVTY Q3 Earnings Beat Estimates on Life Sciences Strength, '26 View Up
Revvity's Q3 2026 earnings and revenues beat estimates, fueled by Life Sciences growth and margin expansion, prompting an upward revision to its annual outlook.
Zacks
DexCom to Launch 15-Day G7 CGM System in Canada This November
DXCM's upcoming Canadian launch of the G7 15 Day CGM, offering longer sensor wear and improved convenience, could boost international growth and patient access.
Zacks
BrightSpring Q3 Earnings Beat on Specialty Growth, '26 View Raised
BTSG's Q3 2026 earnings surge 80% as strong pharmacy and home health growth fuel a revenue beat, margin expansion and higher full-year guidance.
Zacks
BD Launches Liverty TIPS Stent Graft to Expand U.S. Treatment
BDX launches its Liverty TIPS Stent Graft in the United States, offering greater precision and flexibility in portal hypertension treatment.
Zacks

Advertisement|Remove ads.